Assyro AI

Orange Book product · Brand (NDA)

VICTRELIS

BOCEPREVIR

Brand (NDA)NDA 202258DISCN MERCK SHARP DOHME

At a glance

May 13, 2011

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 13, 2011

    15 yr 4 mo ago

  2. Today

  3. Patent 8119602 expires

    Listed method-of-use patent (U-1233) expiration.

    Mar 17, 2027

    in 9 mo

  4. Patent 7772178 expires

    Listed drug product patent expiration.

    Nov 11, 2027

    in 1 yr 5 mo

Pharmaceutical detail

Active ingredient

BOCEPREVIR

Strength

200MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 202258

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8119602Mar 17, 2027in 9 mo
U-1233
7772178Nov 11, 2027in 1 yr 5 mo
ProductU-1128
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.